RAP2B and metastatic neoplasm: In particular, PSMB4, RUVBL2 and ANKAR (Figure 3B) EV protein levels were increased, whereas RAP2B, SERPINA12 and IGLV4-69 abundance levels were decreased in the cEVs of patients with metastatic disease (Figure 3C).